Skip to content

H2020FP7HORIZON

Istituto Nazionale Per le Malattie Infettive Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico

Country
ITItaly
Defence projects
0
Projects, all programmes
28
As coordinator
0
EU contribution (CORDIS)
EUR 6,931,556
Active
2008 to 2024

Projects

28 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EVORAEuropean Viral Outbreak Response AllianceHORIZON2024Third partyNot stated
TBVAC-HORIZONImproving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunityHORIZON2023ParticipantEUR 350,250
ISIDOReIntegrated Services for Infectious Disease Outbreak ResearchHORIZON2022ParticipantEUR 42,119
TTV GUIDE TXPERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIALH20202021ParticipantEUR 90,015
BY-COVIDBeyond COVIDHORIZON2021Third partyNot stated
CoNVatCombating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillanceH20202020ParticipantEUR 613,750
EXSCALATE4CoVEXaSCale smArt pLatform Against paThogEns for Corona VirusH20202020ParticipantEUR 116,250
DECISIONA minituarized disposable molecular diagnostics platform for combatting coronavirus infectionsH20202020ParticipantEUR 246,350
KRONOEvaluation of a production ready portable, Point-of-Need Platform (instrument and reagents), direct from nasal swab test for the molecular diagnostic detection of COVID-19 infection.H20202020ParticipantEUR 246,250
ECRAID-PlanEuropean Clinical Research Alliance on Infectious Diseases (ECRAID) - Business PlanH20202019ParticipantEUR 71,350
VHFMoDRADViral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid DiagnosticsH20202019ParticipantEUR 55,763
ERINHA-AdvanceAdvancing European Research Infrastcuture on Highly Pathogenic AgentsH20202019ParticipantEUR 79,037
PEVIAPAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088H20202017ParticipantEUR 273,650
COMBACTE-CDICombatting Bacterial Resistance in Europe - Clostridium Difficile InfectionsH20202017ParticipantEUR 150,260
PITBULPoint-of-Care implementation of TB testing with ultra-fast Local Heating PCRH20202017ParticipantEUR 647,811
ERINHA2European Research Infrastructure on Highly Pathogenic Agents 2H20202016ParticipantEUR 41,250
EHVAEuropean HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidatesH20202016ParticipantEUR 249,964
MofinaMobile Filovirus Nucleic Acid Test – Sofia ref.: 115848H20202015ParticipantEUR 217,992
EbolaMoDRADEbola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843H20202015ParticipantEUR 308,750
FILODIAGUltra-Fast Molecular Filovirus Diagnostics - Sofia ref.: 115844H20202015ParticipantEUR 404,105

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.